In the early and mid-1980s, scientists used phages to express recombinant proteins. The protein was retained inside the virions, so screening required growing viral plaques, creating a stamp of these ...
The human CD81 (hCD81), the most recently proposed receptor of hepatitis C virus (HCV), can especifically bind to HCV envelope glycoprotein 2 (E2). In this study, hCD81-expressing murine NIH/3T3 cells ...
When a person receives a cancer diagnosis, treatment can often include chemotherapy. This method of treating cancer also can affect healthy cells. But what if there was a drug on the market that, ...
GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug ...
With multidrug resistant (MDR) infections on the rise worldwide, researchers have started looking at using bacteriophages – viruses that only infect bacteria – as an alternative to a dwindling arsenal ...
Reviewed by Michael Greenwood, M.Sc. In phage-display, a gene encoding the surface protein of a bacteriophage is replaced with a gene encoding a novel protein. The technique can be used in drug ...
Phage display is an analytical technique used to study protein-protein interactions and the relationship between a protein and the encoding DNA. Phage display begins by incorporating the protein of ...
Adaptive Phage Therapeutics, a clinical-stage company that develops phage therapeutics to counter multidrug-resistant pathogenic bacteria, operates Biosafety Level 2 laboratories and phage ...
GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback